Author: OurCrowd

[VidMob in GlobeNewswire] VidMob appoints Mainardo de Nardis as Executive Chairman

Oct 24, 2023 |

NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) — VidMob, the leading AI creative performance platform today announced the recent appointment of Mainardo de Nardis. In this leadership role, de Nardis will support the executive team in setting the company’s growth strategy. An acclaimed global agency leader, Mainardo de Nardis also brings deep and relevant experience that will support VidMob’s strategic agency relationships. Read more...

Read More

[MeMed in EIN Newswire] MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections

Oct 24, 2023 |

/EIN News/ — TIRAT CARMEL, Israel; BOSTON, MA – 24 October, 2023 – MeMed, a leader in host response technologies, is pleased to announce that it has been awarded a contract valued at $727,799 by the Division of Research, Innovation, and Ventures (DRIVe) of the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA). The contract will support the execution of a randomized controlled trial designed to build on existing clinical utility data demonstrating that MeMed BV can improve patient outcomes. Read more...

Read More

[D-ID in TechCrunch] D-ID’s newest app uses AI to make videos from photographs

Oct 24, 2023 |

D-ID, the Tel Aviv-based startup best known as the tech behind those viral videos of animated family photos, is bringing its AI video technology to a new mobile app, launching today. Originally available as a web platform, D-ID’s Creative Reality Studio allows users to upload a still image and script and then turn that into an AI-generated video. The technology can be used to create digital representations of themselves, historical figures, fictional characters, presenters or brand ambassadors. Read...

Read More

[Alpha Tau in GlobeNewswire] Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. appointed to Alpha Tau advisory board

Oct 24, 2023 |

JERUSALEM, Oct. 24, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Stephen M. Hahn, M.D., former commissioner of the U.S. Food and Drug Administration (“FDA”), has joined its Scientific Advisory Board. A distinguished expert in the field of radiation oncology and translational/clinical research, and a renowned physician, Dr. Hahn brings a wealth of regulatory and scientific experience to the Company as it advances its Alpha DaRT technology towards FDA clearance. Read...

Read More

[RideVision in Fast Company] Here’s how AI is driving road safety in the Middle East

Oct 23, 2023 |

In August, Dubai made a significant stride in its road safety push by introducing AI-powered pedestrian crossings that incorporate interactive warning systems in accident-prone areas. Last week, Dubai Police unveiled a new mechanism for managing minor traffic accidents by leveraging AI technologies. The new mechanism analyzes minor accidents and instantly issues reports to drivers without human intervention. Read more...

Read More